Filing Details
- Accession Number:
- 0000899243-22-037048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-25 17:30:10
- Reporting Period:
- 2022-11-22
- Accepted Time:
- 2022-11-25 17:30:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1830214 | Ginkgo Bioworks Holdings Inc. | DNA | Biological Products, (No Disgnostic Substances) (2836) | 872652913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1845677 | R Jason Kelly | C/O Ginkgo Bioworks Holdings, Inc. 27 Drydock Avenue Boston MA 02210 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2022-11-22 | 101,813 | $2.04 | 20,418,075 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2022-11-23 | 99,798 | $1.99 | 20,318,277 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
Billionaire Hedge Funds
